Generation Mining Limited

Generation Mining Limited est une société d'exploration et de développement de métaux précieux et de base ayant divers intérêts dans l'ensemble du Canada. Son principal objectif est d'explorer et de développer davantage le projet Davidson Molybdenum en Colombie-Britannique et ses autres propriétés minières, et de continuer à accroître son portefeuille d'actifs immobiliers de métaux précieux et précieux au moyen d'acquisitions.

Français

Generation Mining Limited

Generation Mining Limited is a base metal exploration and development company with various property interests throughout Canada. Its primary business objective is to explore and further develop these properties, and to continue to increase its portfolio of base and precious metal property assets through acquisition.

Anglais

Red Lake Gold Inc.

La société exerce des activités d'exploration minérale et d'acquisition d'actifs miniers en Colombie-Britannique. Son objectif est de localiser et de développer des propriétés économiques précieuses et de base en métaux communs et de mener son programme d'exploration sur la propriété du lac Lennac.

Français

Taiga Gold Corp.

Taiga Gold Corp is a junior exploration company focussed on the search for economic gold mineralization in Northern Saskatchewan. The company’s projects are located near the Seabee Gold Operation, with its’ flagship Fisher Project currently under option to SSR Mining Inc., operators of the Seabea and Santoy mines. Taiga continues to aggressively explore its additional properties in the area and conducts active research to identify new acquisitions. Taiga was formed through a plan of arrangement with parent company Eagle Plains Resources Ltd. in April, 2018.

Anglais

XORTX Therapeutics Inc.

XORTX Therapeutics Inc. is a pharmaceutical company with two clinically advanced products in development – XRx-008 for Autosomal Dominant Polycystic Kidney Disease (ADPKD), XRx-101 for Coronavirus / COVID-19 infection and XRx-225 is a pre-clinical stage program for Type 2 Diabetic Nephropathy (T2DN). XORTX is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. At XORTX Therapeutics, we are dedicated to developing medications to improve the quality of life and future health of patients. Additional information on XORTX Therapeutics is available at www.xortx.com.
Anglais

Bexar Ventures Inc.

Bexar Ventures est une société de logiciels spécialisée dans les plates-formes de formation et de test basées sur le cloud destinées aux entreprises et aux établissements d'enseignement supérieur.  

Français

Cognetivity Neurosciences Ltd.

Cognetivity Neurosciences Ltd. is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA) for use in medical and commercial environments. Cognetivity’s ICA uses Artificial Intelligence and machine learning techniques to help detect the earliest signs of impairment by testing the performance of large areas of the brain, potentially allowing early diagnosis of dementia. Cognetivity aims to develop the ICA through planned clinical studies to the market in North America and Europe.

Anglais